Pediatric and adult patients with SSTR-2-positive tumors according to [68Ga]Ga-DOTATOC/DOTATE PET (including NET, meningioma, neuroblastoma, and medulloblastoma) not amenable to standard treatment after failure of first-line treatment. The gene discussed is SSTR2; the disease is medulloblastoma.